FibroGen Inc (NASDAQ:FGEN) has a beta value of 0.86 and has seen 1.2 million shares traded in the last trading session. The company, currently valued at $108.42M, closed the last trade at $1.09 per share which meant it gained $0.05 on the day or 4.81% during that session. The FGEN stock price is -1686.24% off its 52-week high price of $19.47 and 69.72% above the 52-week low of $0.33. The 3-month trading volume is 2.77 million shares.

FibroGen Inc (NASDAQ:FGEN) trade information

Sporting 4.81% in the green in last session, the stock has traded in the red over the last five days, when the FGEN stock price touched $1.09 or saw a rise of 13.49%. Year-to-date, FibroGen Inc shares have moved 22.98%, while the 5-day performance has seen it change -4.39%. Over the past 30 days, the shares of FibroGen Inc (NASDAQ:FGEN) have changed -53.62%.

FibroGen Inc (FGEN) estimates and forecasts

Figures show that FibroGen Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 103.74% over the past 6 months, with this year growth rate of 59.18%, compared to 10.50% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 48.10% and 56.70% for the next quarter. Revenue growth from the last financial year stood is estimated to be 5.20%.

2 analysts offering their estimates for the company have set an average revenue estimate of $36.67 million for the current quarter. 2 have an estimated revenue figure of $37.67 million for the next quarter concluding in Jun 2024.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -23.23% over the past 5 years.

FGEN Dividends

FibroGen Inc is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.